The pieces are falling into place—including the explanation for Goldman Sachs’ seemingly odd behavior. Goldman’s insight was realizing that NVS/MNTA’s patent-infringement suit would put a damper on Bill Marth’s Lovenox propaganda, and hence Goldman itself could drive MNTA’s share price higher by inviting Marth to speak at Goldman’s conference.
The reason for Goldman’s lowball price target of $15 in its 12/20/10 MNTA report was plainly to allow clients to buy in before Marth’s appearance at today’s conference.
Market Data 
Markets 
AI
